3 Reasons to Avoid SpaceX Stock When It IPOs

The article warns investors against buying into SpaceX's expected $2 trillion IPO, citing AI-related losses of nearly $5 billion in 2025, a slowing core business with 18% revenue growth, and political/regulatory risks tied to Elon Musk. It argues retail buyers would be arriving late to a massive company while taking on uncertain cash flow and governance risks. The piece is opinion-driven and unlikely to move markets immediately, but it could shape sentiment around the planned IPO.

Analysis

The market is being asked to underwrite a mature, already-systemic asset at a venture-style multiple while the company’s next leg of growth appears to be financed by a capital-intensive adjacent bet rather than by the core franchise. That is usually a poor setup for post-IPO price discovery: when the “new story” is doing the heavy lifting, the public listing becomes a funding event more than a rerating event. In that structure, the burden of proof shifts from growth at any cost to growth with visible unit economics, and that transition tends to compress multiples rather than expand them.

The second-order issue is competitive opportunity cost. If capital and management attention are diverted toward AI, then the core space platform can become a cash generator that is underinvested relative to its strategic importance, while smaller private rivals, subcontractors, and launch-adjacent suppliers can pick up incremental share without carrying the same headline risk. Public-market investors often miss this: the most attractive long may not be the platform itself, but the picks-and-shovels ecosystem that benefits if the incumbent stumbles or slows.

Politics is the clearest catalyst with asymmetric downside because it introduces discontinuous rather than linear risk. Even a modest increase in regulatory friction, procurement scrutiny, or launch-permission delays can matter more than near-term revenue growth, since the valuation already discounts a lot of operational excellence. The setup implies a long-dated overhang: days for initial IPO pop/fade dynamics, months for lockup and revised guidance, and years for contract/regulatory dispersion tied to the founder’s brand.

The contrarian view is that the market may be underestimating how much public listing could actually de-risk the franchise by broadening access to capital and deepening the moat. But at a $2T-plus entry point, that optionality is probably already priced in. The better expression is not chasing the IPO, but waiting for the first post-listing dislocation when narrative fades and underwriting discipline finally matters.

Key Decisions for Investors

• Avoid buying the IPO in the first 30-60 days; wait for post-listing price discovery and insider-lockup expiry, when valuation compression is most likely if AI losses remain salient.
• Use any initial pop to initiate a tactical short via puts or put spreads on the listed shares, targeting a 3-6 month window where sentiment can shift from scarcity premium to capital-allocation scrutiny.
• Pair trade: long the broader space supply chain / launch-enabler basket, short the issuer, to express the view that the ecosystem can outperform even if the flagship listing underwhelms.
• If exposed to TSLA, reduce position size or hedge around election/regulatory headlines; founder political spillover is a higher-probability negative catalyst than core-business deterioration over the next 6-12 months.
• Do not short into the IPO print itself; wait for liquidity normalization and analyst initiation, when borrow is easier and the risk/reward of fading optimism improves materially.